Skip to main content
European Commission logo
polski polski
CORDIS - Wyniki badań wspieranych przez UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary
Zawartość zarchiwizowana w dniu 2024-06-18

Resistance in Gram-Negative Organisms: Studying Intervention Strategies

Cel

Antibiotics are a mainstay of public health, but their use has increased exponentially leading to the emergence of antibiotic resistance. The R-GNOSIS (Resistance in Gram-Negative Organisms: Studying Intervention Strategies) project combines 5 international clinical studies, all supported by highly innovative microbiology, mathematical modelling and data-management, to determine - in the most relevant patient populations - the efficacy and effectiveness of cutting-edge interventions to reduce carriage, infection and spread of Multi-Drug Resistant Gram-negative Bacteria (MDR-GNB). All work-packages will progress science beyond the state-of-the-art in generating new and translational clinically relevant knowledge, through hypothesis-driven studies focussed on patient-centred outcomes.
The 5 clinical studies will investigate the following interventions:
•A Point-Of-Care-Testing guided management strategy to improve appropriate antibiotic prescription for uncomplicated UTI in primary care.
•Gut decolonization in outpatients with intestinal carriage of MDR-GNB.
•A “test and prescribe” strategy, based on rapid diagnostic testing of faeces for MDR-GNB to optimize antibiotic prophylaxis in colo-rectal surgery.
•Contact Isolation of patients with ESBL-producing Enterobacteriaceae in general hospital wards.
•Three Decolonization strategies in ICUs.
Seven laboratories across Europe will perform microbiological analyses, as well as unique quantitative experiments. All information will be integrated by 3 groups of mathematical modellers into highly innovative models to better understand and predict future trends and effects of interventions. The studies and analyses proposed in R-GNOSIS will generate a step-change in identifying evidence-based preventive measures and clinical guidance for primary care and hospital-based physicians and health-care authorities, to combat the spread and impact of infections caused by MDR-GNB in Europe.

Zaproszenie do składania wniosków

FP7-HEALTH-2011-single-stage
Zobacz inne projekty w ramach tego zaproszenia

Koordynator

UNIVERSITAIR MEDISCH CENTRUM UTRECHT
Wkład UE
€ 4 164 036,18
Adres
HEIDELBERGLAAN 100
3584 CX Utrecht
Niderlandy

Zobacz na mapie

Region
West-Nederland Utrecht Utrecht
Rodzaj działalności
Higher or Secondary Education Establishments
Kontakt administracyjny
E. Van Geenen (Dr.)
Linki
Koszt całkowity
Brak danych

Uczestnicy (23)